Assessing the effect of platelet infusion in reducing hemorrhage during CABG surgery in patients under plavix treatment

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

IRCT

Registry ID

IRCT20200902048590N1

Enrollment

120

Registered

2020-10-31

Start date

2017-10-30

Completion date

Unknown

Last updated

2020-11-30

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

?????? ???? ?????. Other specified complications of cardiac and vascular prosthetic devices, implants and grafts

Interventions

Intervention 1: Intervention group: platelet infusion. Intervention 2: Control group: Routine treatment (NO platelet injection).

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Using plavix Need for coronary artery bypass Being unable to hold plavix Informed consent

Exclusion criteria

Exclusion criteria: Patient's dissatisfaction and the desire to cut off cooperation Incidence of complications

Design outcomes

Primary

Measure	Time frame
Bleeding amount. Timepoint: 1, 6, 12, 24, and 48 hours after surgery. Method of measurement: Assessing the amount of packed cell needed.	—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactDr.Seyyed Hamid Reza Hoseinikhah

Mashhad University of Medical Sciences

hoseinikhahh@mums.ac.ir+98 51 3501 7699

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026